期刊文献+

多发性骨髓瘤继发心肌淀粉样变性1例并文献复习

原文传递
导出
摘要 目的报道1例多发性骨髓瘤(MM)继发心肌淀粉样变性患者3. 5年的诊治过程,总结治疗经验及获益。方法对本例患者的临床资料进行分析,并结合相关文献进行复习。结果本例临床获益:(1)诊断早;(2)硼替佐米采用皮下注射方式,3. 5年无周围神经系统不良反应;(3)治疗后血清游离轻链比率正常化且出现异常蛋白条带,提示预后良好;(4)淀粉样变性器官功能改善明显,延长了生存期。结论 MM继发心脏淀粉样变性,若能早期诊断和迅速进行"源头治疗",亦能获得非常好的血液学缓解及器官功能改善,进而延长生存期。
出处 《中国临床研究》 CAS 2019年第1期97-99,共3页 Chinese Journal of Clinical Research
  • 相关文献

参考文献4

二级参考文献32

  • 1Gillmore JD, Wechalekar A, Bird J, et al. Guidelines on the diagnosis and investigation of AL amyloidosis [J]. Br J Haematol, 2015, 168(2): 207-218.
  • 2Gertz MA. Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment [J]. Am J Hematol, 2014, 89(12): 1132-1140.
  • 3Comenzo RL, Reece D, Palladini G, et al. Consensus guidelines for the conduct and reporting of clinical trials in systemic light- chain amyloidosis [J]. Leukemia, 2012, 26 (11): 2317-2325.
  • 4Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders [J]. Leukemia, 2009, 23(2): 215-224.
  • 5Leung N, Nasr SH, Sethi S. How 1 treat amyloidosis: the impor- tance of accurate diagnosis and amyloid typing [ J]. Blood, 2012, 120( 16): 3206-3213.
  • 6Dispenzieri A, Gertz MA, Kyle RA, et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis [J]. J Clin Oncol, 2004, 22( 18): 3751-3757.
  • 7Kumar S, Dispenzieri A, Lacy MQ, et al. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements [J]. J Clin Oncol, 2012, 30(9): 989-995.
  • 8Palladini G, Dispenzieri A, Gertz MA, et al. New criteria for response to treatment in immunoglobulin light chain amyloidosis based on free light chain measurement and cardiac biomarkers: impact on survival outcomes [J]. J Clin Oncol, 2012, 30(36):4541-4549.
  • 9Leung N, Glavey SV, Kumar S, et al. A detailed evaluation of the current renal response criteria in AL amyloidosis: is it time for a revision? [J]. Haematologica, 2013, 98 (6): 988-992.
  • 10Girnius S, Seldin DC, Cibeira MT, et al. New hematologic response criteria predict survival in patients with immunoglobulin light chain amyloidosis treated with high-dosemelphalan and autologous stem-cell transplantation [J]. J Clin Oncol, 2013, 31 (21): 2749-2750.

共引文献473

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部